Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 19-Nov-24
Select bar for recommendation details.
Recommendations | 19-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Lineage Cell Therapeutics Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a 733.33% increase from the last price of 0.600.
High | 1,066.7% | 7.00 |
Med | 733.3% | 5.00 |
Low | 400.0% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate | +12.50% |
Average growth rate | -24.60% |
More ▼
Revenue history & estimates in USD
Average growth rate | +50.66% |
Average growth rate | +72.31% |
More ▼